Ali Aminian

24PUBLICATIONS
25CO-AUTHORS
Gene and molecular therapyBehavioural epidemiologyMedical biochemistry - carbohydratesMetabolic medicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 25, 2026
Cost-Effectiveness of Pharmacologic Therapies for Metabolic Dysfunction-Associated Steatohepatitis With Significant Fibrosis in the United States.

|Mar 12, 2026
Obesity Treatments and Weight Changes in Clinical Practice After Discontinuation of Semaglutide or Tirzepatide.

Hamlet Gasoyan, Rebecca Schulte, Christopher B Boyer

|Jan 19, 2026
Effect of Social Vulnerability on Efficacy of Bariatric Surgery Versus Medical and Lifestyle Intervention for Type 2 Diabetes: Analysis of the ARMMS-T2D Consortium of Randomized Trials.

Mary Elizabeth Patti, Bo Hu, Sarah Kirschling

|Sep 16, 2025
Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity.

Hamlet Gasoyan, Mohammad Hesam Alavi, Alexander Zajichek

|Feb 04, 2025
Health-Related Quality of Life and Health Utility After Metabolic/Bariatric Surgery Versus Medical/Lifestyle Intervention in Individuals With Type 2 Diabetes and Obesity: The ARMMS-T2D Study.

Donald C Simonson, William F Gourash, David E Arterburn

|Jan 27, 2025
Long-term liver outcomes after metabolic surgery in compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis.

Ali Aminian, Abdullah Aljabri, Sarah Wang

Pageof 4

Frequent Collaborators

3 joint publications

Donald C Simonson

2 joint publications

Hamlet Gasoyan

2 joint publications

John P Kirwan

2 joint publications

David E Arterburn